Table 2 Baseline characteristics of the study groups

Number of individuals

20

50

39

11

Age (years)

41.60 ± 12.95

45.40 ± 12.68

46.85 ± 12.76

40.27 ± 11.46

Sex (F/M)

14/6

33/17

23/16

10/1

Smoking, n (%)

-

38

46.2

9.1

Disease duration (months)

-

5.92 ± 5.10

6.10 ± 4.55

5.27 ± 6.96

CAS

-

3.36 ± 1.14

3.79 ± 0.86

1.82 ± 0.41

FT3 (pmol/L)

-

6.16 ± 3.82

6.47 ± 4.25

5.07 ± 1.11

FT4 (pmol/L)

-

18.32 ± 9.78

18.86 ± 10.95

16.41 ± 2.72

TSH (mIU/L)

-

1.87 ± 2.49

1.88 ± 2.60

1.81 ± 2.14

TRAb (IU/L)

-

8.99 ± 11.34

9.37 ± 11.21

7.63 ± 12.24